Novartis AG (NYSE:NVS)
| 84.48 Delayed Data As of Oct 20 |  +1.33 / +1.60%Today’s Change | 77.04 Today|||52-Week Range 98.52 | -10.54% Year-to-Date |
Latest NVS News | Press Releases
Today’s Trading
| Previous close | 83.15 |
| Today’s open | 84.17 |
| Day’s range | 84.09 - 84.96 |
| Volume | 2,282,294 |
| Average volume (3 months) | 1,829,059 |
| Market cap | $182.0B |
Data as of 4:00pm ET, 10/20/2021
Growth & Valuation
| Earnings growth (last year) | +15.91% |
| Earnings growth (this year) | -92.09% |
| Earnings growth (next 5 years) | +8.00% |
| Revenue growth (last year) | +2.95% |
| P/E ratio | 21.4 |
| Price/Sales | 4.43 |
| Price/Book | 3.24 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AZNAstraZeneca | +0.46 | +0.76% |
| ABBVAbbVie | +0.99 | +0.92% |
| NVONovo Nordisk | -0.11 | -0.11% |
| MRKMerck | +1.58 | +1.99% |
Data as of 5:52pm ET, 10/20/2021
Financials
| Next reporting date | October 26, 2021 |
| EPS forecast (this quarter) | $1.64 |
| Annual revenue (last year) | $48.9B |
| Annual profit (last year) | $8.1B |
| Net profit margin | 16.59% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Basel, Basel-stadt (basle Town) |
Forecasts
